Abstract
Mitochondrial uncoupling protein-4 (UCP4) enhances neuronal cell survival in MPP+-induced toxicity by suppressing oxidative stress and preserving intracellular ATP and mitochondrial membrane potential. UCP4 expression is increased by MPP+, but its regulation is unknown. Using serial human UCP4 promoter-luciferase reporter gene constructs, we identified and characterized several cis-acting elements that can regulate UCP4 expression. Core promoter activity exists within 100 bp upstream of the transcription initiation site (TIS = + 1). Both CAAT box (-33/-27) and Sp1 (62/-49) elements are crucial and act synergistically in its transcription. We identified a NF-kappa B putative binding site at -507/-495. Mutation of this site significantly decreased UCP4 promoter activity. Activation of NF-kappa B by TNF alpha or cycloheximide increased, whereas its inhibition by 4-hydroxy-2-nonenal or transfection of pI kappa B alpha M suppressed, UCP4 promoter activity. NF-kappa B inhibition significantly suppressed the MPP+-induced increase in UCP4 expression. MPP+ increased specific binding of NF-kappa B protein complexes to this site in electrophoretic mobility shift assay. Both UCP4 knockdown and NF-kappa B inhibition exacerbated MPP+-induced cell death. We present the first direct evidence that UCP4 is regulated by NF-kappa B, mediated via a functional NF-kappa B site in its promoter region, and that UCP4 has a significant role in NF-kappa B prosurvival signaling, mediating its protection against MPP+ toxicity. (C) 2010 Elsevier Inc. All rights reserved.
Original language | English |
---|---|
Pages (from-to) | 192-204 |
Number of pages | 13 |
Journal | Free Radical Biology and Medicine |
Volume | 49 |
Issue number | 2 |
DOIs | |
Publication status | Published - 1 Jul 2010 |
Keywords
- UCP
- Parkinson disease
- Nuclear factor kappa B
- Promoter
- Oxidative stress
- Free radicals
- Uncoupling protein 4
- Transcription regulation
- Mitochondrial dysfunction